Kingmed Diagnostics
Kingmed Diagnostics
Kingmed Diagnostics is a third-party medical inspection service provider.
Kingmed Diagnostics, established in 1994, is a third-party medical inspection and pathological diagnosis service provider, mainly engaging in third-party medical assessment and pathological diagnosis business and providing leading medical diagnosis information integration services and and pathological diagnosis outsourcing services for medical institutions at all levels across the country. Founded by Guangzhou Medical University, it went public in September 2017. Its main shareholder is Liang Yaoming, and peer companies are Transtek Medical Electronics and Inkon Life Technology.
- All
- News
- Analysis
- Research
Briefing Nov 26, 2021 09:41 AM
· Healthcare
Longhui medical completed nearly 100 million yuan of round B financing, and Shanlan capital and Sinopharm capital jointly led the investment
Briefing Nov 26, 2021 09:32 AM
· Healthcare
Yueying technology completed hundreds of millions of yuan of a + round financing and deeply cultivated heart brain computing medicine
In depth
Healthcare
Backed up by Rich Dad – What’s Next for Ping An Good Doctor?
Having a rich dad can help with capital and connections when a company is at the ‘infant’ stage. But being independent comes sooner or later. When shall that be for Ping An Good Doctor? Or will it not come at all?
Aug 27, 2020 01:02 PM
Briefing Nov 17, 2021 06:02 PM
Gilid signed an agreement with science and technology to deepen strategic cooperation in the areas of chronic hepatitis B, hepatitis C and HIV infection.
Briefing Oct 27, 2021 09:12 AM
· Healthcare
Saile medical completed the a + round of financing and accelerated the layout of oral digital field
Research
Healthcare, Technology, Consumer StaplesWIA2020 | Rising Tech Stars 2020: Global & China's 100
Dec 09, 2020 09:57 AM
Dec 09, 2020 09:39 AM
Research
Real Estate, Industrials, FinancialsTech for Global, Globalization Footprints of the Established and the New
May 29, 2020 08:30 PM
Research
Real Estate, Industrials, FinancialsLow-Carbon Industry Expansion - Key Studies From Chinese Companies
May 28, 2020 12:40 PM
Briefing Sep 30, 2021 02:41 PM
· Healthcare
AstraZeneca acquires Caelum Biosciences overweight rare diseases business
Briefing Sep 27, 2021 11:57 AM
· Healthcare
Triarm therapeutics completed a round of financing of US $60 million
Briefing Aug 31, 2021 05:29 PM
· Healthcare
Dashi pharmaceutical completed a round of financing of nearly 100 million yuan
Briefing Jul 29, 2021 10:01 AM
Back to Hong Kong, Chinese concept stocks rose collectively, and Wanguo data rose 17.5%
Briefing Jul 02, 2021 02:10 PM
· Healthcare
Li Jidian: the production capacity of next year has been fully reserved, and it can be listed before the end of the year
Insight
Briefing May 27, 2021 02:02 AM
· Healthcare
Alibaba Health Information publishes rather poor annual figures
Briefing May 21, 2021 12:17 AM
· Healthcare
Medtech company So-Young International with surprisingly good growth figures
Briefing Feb 09, 2021 08:39 AM
· Healthcare
Tens of millions of strategic investment from CommScope
Briefing Feb 07, 2021 06:00 PM
· Healthcare
Shenzhi technology completed tens of millions of RMB B + round financing
See more
Related Companies
EqualOcean Analysis
- Digital Health on a Rise: JD Health Stocks Spike 70% on First Trading Day
- As Crackdown Looms, Chinese Insurtech Waterdrop Enters Next Growth Phase
- Ding Dang Kuai Yao: A Chinese E-Commercial Way to Run a Pharmacy
- Black Swans and Breakthroughs: China's Top 50 Innovative Public Firms in 2020
- Ali Health Aims Higher with Rebranding and New Strategies
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.